AstraZeneca CEO says might run new global trial of its COVID-19 vaccine: Report

AstraZeneca and the University of Oxford announced this week that their inexpensive, easy-to-produce coronavirus vaccine appeared effective, with the average efficacy of about 70 percent..
AstraZeneca CEO says might run new global trial of its COVID-19 vaccine: Report. This article is published at 20 January 2021 09:40 from Money Control India Financial News, click on the read full article link below to see further details.